MDMA/ecstasy treatment against PTSD recommended for rejection by FDA.

Slate Magazine

The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think

This is a huge setback for psychedelic advocates, but it’s ultimately good for patients.

A pity that a bad trial design from Lykos doesn't allow to really answer this interesting question and offee a potential treatment opportunity for people that suffer. #science #mdma #psychedelics

Interesting pre-print how Chat GTP & LLMs are changing the way scientific publications are written:

Delving into ChatGPT usage in academic writing through excess vocabulary

Kind of understandable that especially non-English-native speakers make use of it to polish their articles. But words matter, especially when trying to describe a new finding as scientifically accurate as possible. I wonder to what extend this verbose and flowery language is then really understood by the authors themselves and whether or not those words really correctly describe their findings or not. #science #writing #ai

Is it just me or does there seem to be an influx of bots and scammers arriving to #Nostr lately? It looks like more and more of "DM me for my cool financial trick" or "join my newsletter on how to earn money with #bitcoin mining" replies are popping up in more and more posts.

Europe's EMEA recommends to refuse Leqembi, Eisai's "anti-Alzheimer's" antibody. It's approved by the FDA in the US. I think the EMEA is making the right call. The clinical data and modest improvements (if any) are really not convincing imo.

European Medicines Agency (EMA)

Leqembi | European Medicines Agency (EMA)

#science #neuroscience